Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study

Clinical Immunology

Volumn 150, Issue 2, 2014, Pages 137-139

  Audrain, Marie ^a   Thomas, Caroline ^a   Mirallie, Sophie ^a   Bourgeois, Nathalie ^a   Sebille, Véronique ^a   Rabetrano, Hasina ^b   Durand Zaleski, Isabelle ^b   Boisson, Rachel ^a   Persyn, Mathieu ^a   Pierres, Cécile ^a   Mahlaoui, Nizar ^c,d   Fischer, Alain ^c,d  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Neonatal screening; Quantification of TRECs; SCID; Severe combined immunodeficiency

Indexed keywords

T LYMPHOCYTE RECEPTOR;

CD4+ T LYMPHOCYTE; COST EFFECTIVENESS ANALYSIS; DNA EXTRACTION; HUMAN; LETTER; NEWBORN SCREENING; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERE COMBINED IMMUNODEFICIENCY; T CELL RECEPTOR EXCISION CIRCLE;

NEONATAL SCREENING; QUANTIFICATION OF TRECS; SCID; SEVERE COMBINED IMMUNODEFICIENCY;

FRANCE; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; RECEPTORS, ANTIGEN, T-CELL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84891899409     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.11.012     Document Type: Letter

References (9)

1. Puck J.M. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J. Allergy Clin. Immunol. 2007, 760-768.
2. Brown L., Xu-Bayford J., Allwood Z., Slatter M., Cant A., Davies E.G., Veys P., Gennery A.R., Gaspar H.B. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 2011, 3243-3246.
3. Chan K., Puck J.M. Development of a population-based screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2005, 391-398.
4. Baker M.W., Grossman W.J., Laessig R.H., Hoffman G.L., Brokopp C.D., Kurtycz D.F., Cogley M.F., Litsheim T.J., Katcher M.L., Routes J.M. Development of a routine newborn screening protocol for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2009, 522-527.
5. Gerstel-Thompson J.L., Wilkey J.F., Baptiste J.C., Navas J.S., Pai S.Y., Pass K.A., Eaton R.B., Comeau A.M. High-throughput multiplexed T-cell receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening. Clin. Chem. 2010, 1466-1474.
6. Verbsky J., Thakar M., Routes J. The Wisconsin approach to newborn screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2012, 622-627.
7. Comeau A.M., Hale J.E., Pai S.Y., Bonilla F.A., Notarangelo L.D., Pasternack M.S., Meissner H.C., Cooper E.R., DeMaria A., Sahai I., Eaton R.B. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J. Inherit. Metab. Dis. 2010, S273-S281.
8. Kwan A., Church J.A., Cowan M.J., Agarwal R., Kapoor N., Kohn D.B., Lewis D.B., McGhee S.A., Moore T.B., Stiehm R.R., Porteus M., Aznar C.P., Currier R., Lorey F., Puck J.M. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2years. J. Allergy Clin. Immunol. 2013, 140-150.
9. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., Polis M.A., Haase A.T., Feinberg M.B., Sullivan J.L., Jamieson B.D., Zack J.A., Picker L.J., Koup R.A. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998, 690-695.